BIOLOCO
Annual accounts 2025
micro format, filed on 17-06-2026, 44 days before the deadlineTurnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €210,000. Estimated: probably between €130,000 and €350,000.
Balance sheet
balance sheet total €9,583 on 31-12-2025in euro
in euro
Position in the sector
-
Higher than 7% of 16,298 companies in 2022.
0.07
Lower than 95% of 17,864 companies in 2025.
179.5%
Higher than 95% of 17,961 companies in 2025.
Net result: middle half · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: bottom quarter
Staff
Staff costs divided by the average number of full-time equivalents.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||||
20/58 |
9,583 | 8,991 | 2,443 | 62,444 | 71,905 | 95,753 | 92,853 | |
21/28 |
1,747 | 245 | 245 | 52,916 | 64,997 | 77,077 | 89,158 | |
22/27 |
1,503 | - | - | 52,671 | 64,752 | 76,833 | 88,914 | |
23 |
- | - | - | 16,143 | 21,122 | 26,101 | 31,081 | |
24 |
1,503 | - | - | 646 | 1,507 | 2,368 | 3,229 | |
26 |
- | - | - | 35,883 | 42,123 | 48,364 | 54,604 | |
28 |
245 | 245 | 245 | 245 | 245 | 245 | 245 | |
29/58 |
7,836 | 8,747 | 2,199 | 9,528 | 6,909 | 18,676 | 3,695 | |
3 |
1,933 | 2,453 | - | 4,342 | 4,670 | 7,652 | - | |
30/36 |
1,933 | 2,453 | - | 4,342 | 4,670 | 7,652 | - | |
40/41 |
4,040 | 4,181 | 645 | 842 | - | 9,746 | 2,142 | |
40 |
3,543 | 3,448 | 645 | 842 | - | 8,514 | 1,979 | |
41 |
497 | 733 | - | - | - | 1,232 | 163 | |
54/58 |
156 | 487 | 1,553 | 1,298 | 2,182 | 1,224 | 1,408 | |
490/1 |
1,708 | 1,627 | - | 3,046 | 56 | 54 | 145 | |
| Balance sheet: equity and liabilities | ||||||||
10/49 |
9,583 | 8,991 | 2,443 | 62,444 | 71,905 | 95,753 | 92,853 | |
10/15 |
-98,489 | -115,689 | -133,393 | -112,036 | -102,984 | -57,528 | -46,187 | |
10/11 |
6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | |
100 |
- | - | - | - | - | - | 18,600 | |
101 |
- | - | - | - | - | - | 12,400 | |
14 |
-104,689 | -121,889 | -139,593 | -118,236 | -109,184 | -63,728 | -52,387 | |
17/49 |
108,073 | 124,680 | 135,837 | 174,480 | 174,889 | 153,281 | 139,039 | |
17 |
- | - | - | 3,607 | 12,052 | 20,206 | 24,178 | |
170/4 |
- | - | - | 3,607 | 12,052 | 20,206 | 24,178 | |
42/48 |
108,073 | 124,680 | 135,837 | 170,873 | 160,299 | 133,075 | 114,861 | |
42 |
- | - | 3,607 | 8,445 | 8,155 | 7,875 | 7,738 | |
44 |
5,998 | 6,624 | 11,459 | 50,566 | 43,503 | 32,024 | 22,379 | |
440/4 |
5,998 | 6,624 | 11,459 | 50,566 | 43,503 | 32,024 | 22,379 | |
45 |
250 | 762 | 1,266 | 7,741 | 12,744 | 2,628 | 1,744 | |
450/3 |
250 | 762 | 985 | 5,823 | 2,311 | 127 | 1,555 | |
454/9 |
- | - | 280 | 1,918 | 10,433 | 2,502 | 189 | |
47/48 |
101,825 | 117,295 | 119,505 | 104,121 | 95,897 | 90,547 | 83,000 | |
492/3 |
- | - | - | - | 2,539 | - | - | |
| Income statement | ||||||||
9900 |
18,288 | 18,599 | 54,795 | 38,480 | 21,448 | 46,737 | 38,362 | |
62 |
- | - | 21,781 | 32,041 | 51,778 | 40,420 | 71,142 | |
630 |
207 | - | 1,873 | 12,081 | 12,081 | 12,081 | 15,101 | |
640/8 |
734 | 1,218 | 51,400 | 1,171 | 810 | 1,220 | 1,381 | |
66A |
- | - | - | - | - | 1,582 | 52 | |
9901 |
17,346 | 17,381 | -20,259 | -6,812 | -43,221 | -8,565 | -49,314 | |
75/76B |
227 | 582 | 537 | 322 | 173 | 119 | 104 | |
75 |
227 | 582 | 537 | 322 | 173 | 119 | 103 | |
76B |
- | - | - | - | - | - | 1 | |
65/66B |
373 | 259 | 1,636 | 2,312 | 2,348 | 2,787 | 3,159 | |
65 |
373 | 259 | 1,636 | 2,312 | 2,348 | 2,787 | 3,159 | |
9903 |
17,200 | 17,704 | -21,358 | -8,802 | -45,396 | -11,233 | -52,369 | |
67/77 |
- | - | - | 250 | 60 | 109 | 18 | |
9904 |
17,200 | 17,704 | -21,358 | -9,052 | -45,456 | -11,341 | -52,387 | |
9905 |
17,200 | 17,704 | -21,358 | -9,052 | -45,456 | -11,341 | -52,387 | |
| Appropriation of the result | ||||||||
9906 |
-104,689 | -121,889 | -139,593 | -118,236 | -109,184 | -63,728 | -52,387 | |
14P |
-121,889 | -139,593 | -118,236 | -109,184 | -63,728 | - | - | |
| Social balance sheet | ||||||||
9087 |
- | - | 1 | - | 3.6 | 2.7 | 2.8 | |
Hours worked1013 |
- | 0 | - | - | 2,325 | 1,914 | 4,469 | |
| Document | ||||||||
The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 17-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 17-06-2026 | 2026-00167698 | |
| 31-12-2024 | micro format | 22-08-2025 | 2025-00466910 | |
| 31-12-2023 | micro format | 19-08-2024 | 2024-00360619 | |
| 31-12-2022 | micro format | 04-08-2023 | 2023-00313202 | |
| 31-12-2021 | micro format | 31-08-2022 | 2022-20389610 | |
| 31-12-2020 | micro format | 02-08-2021 | 2021-45700132 | |
| 31-12-2019 | micro format | 24-07-2020 | 2020-34600597 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| 17,554 | - | -18,385 | 5,269 | -31,140 | 3,516 | -34,213 | ||
| 17,407 | - | -19,484 | 3,029 | -33,375 | 739 | -37,286 | ||
| 1,710 | - | -50,798 | 0 | 0 | 0 | 104,259 | ||
| -331 | -1,067 | 256 | -885 | 959 | -184 | - | ||
| -100,237 | -115,934 | -133,638 | -161,345 | -153,390 | -114,399 | -111,167 | ||
| - | - | - | -179.4% | -143.2% | -60.1% | -49.7% | ||
| 0.07 | 0.07 | - | 0.06 | 0.04 | 0.14 | 0.03 | ||
| 0.05 | 0.05 | - | 0.03 | 0.01 | 0.08 | 0.03 | ||
| 179.5% | 196.9% | - | -14.5% | -63.2% | -11.8% | -56.4% | ||
| 47.03 | - | -11.24 | 2.28 | -13.26 | - | - |
A ratio outside any meaningful range has been withheld (balance sheet total €9,583, equity -€98,489).
Debt to equity is not shown because equity is negative. Debt divided by negative equity means nothing.
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Social balance sheet
| Item | 31-12-2024 | 31-12-2023 | 31-12-2021 |
|---|---|---|---|
| Employees at the balance-sheet date | 0 | 0 | 6 |
| full-time | 0 | 0 | 3 |
| part-time | 0 | 0 | 3 |
| in full-time equivalents | - | - | 3.7 |
| - | 1 | 3.6 | |
| On a permanent contract | - | - | 2 |
| Joined | - | 27 | 8 |
| Left | - | 30 | 8 |
Source: social balance sheet in the 2021 to 2024 annual accounts
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | €1,710 | - | - | - | - |
| €207 | - | €1,873 | €12,081 | €12,081 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on BIOLOCO
The operating result for 2025 is 0% lower than in 2024.
Equity is negative. Debt (€108,073) exceeds the balance-sheet total (€9,583).